Understanding the maturation of white blood cells to find new therapies against lymphoblastic leukemia

byJosep Carreras Leukaemia Research InstitutePax5 K198 acetylation regulates gene expression. Credit:Nature Immunology(2024). DOI: 10.1038/s41590-024-01995-7More than 400 people, 80%

Updated on: November 10,2024

Understanding the maturation of white blood cells to find new therapies against lymphoblastic leukemia

byJosep Carreras Leukaemia Research InstitutePax5 K198 acetylation regulates gene expression. Credit:Nature Immunology(2024). DOI: 10.1038/s41590-024-01995-7More than 400 people, 80%

Updated on:November 10,2024

Researchers identify barriers to breast cancer screening in vulnerable populations

by Sbarro Health Research OrganizationCredit: Unsplash/CC0 Public DomainWomen of racial and ethnic minorities experience challenges that hinder adherence to regular mammography screenings.In order to

Updated on: February 18,2024

Researchers identify barriers to breast cancer screening in vulnerable populations

by Sbarro Health Research OrganizationCredit: Unsplash/CC0 Public DomainWomen of racial and ethnic minorities experience challenges that hinder adherence to regular mammography screenings.In order to

Updated on:February 18,2024

How sweet it isn't: Diminished taste function affects cancer patients' food intake

by Alissa Nolden,University of Massachusetts AmherstAlissa Nolden is an assistant professor of food science at UMass Amherst. Credit: UMass AmherstThe simple pleasure of tasting and savoring foo

Updated on: May 09,2024

How sweet it isn't: Diminished taste function affects cancer patients' food intake

by Alissa Nolden,University of Massachusetts AmherstAlissa Nolden is an assistant professor of food science at UMass Amherst. Credit: UMass AmherstThe simple pleasure of tasting and savoring foo

Updated on:May 09,2024

Researchers demonstrate that a machine learning model predicts oxaliplatin benefit

by NRG OncologyCredit: Unsplash/CC0 Public DomainThe current standard of care for treating patients with stage 3 colon cancer is to use adjuvant therapy with FOLFOX, a combination of the drugs fluorou

Updated on: May 16,2024

Researchers demonstrate that a machine learning model predicts oxaliplatin benefit

by NRG OncologyCredit: Unsplash/CC0 Public DomainThe current standard of care for treating patients with stage 3 colon cancer is to use adjuvant therapy with FOLFOX, a combination of the drugs fluorou

Updated on:May 16,2024

Study reports progress in long-term protection against ovarian cancer tumors

byWayne State UniversityCharacterization of immune response during ovarian tumor progression. mCherry+ TKO mouse ovarian cancer cells were injected i.p. in C57BL/6 immunocompetent mice (n=50) or

Updated on: January 26,2024

Study reports progress in long-term protection against ovarian cancer tumors

byWayne State UniversityCharacterization of immune response during ovarian tumor progression. mCherry+ TKO mouse ovarian cancer cells were injected i.p. in C57BL/6 immunocompetent mice (n=50) or

Updated on:January 26,2024

Molecular subtypes of advanced kidney cancer matter for treatment response

by Yale Cancer Center/Smilow Cancer HospitalCredit: Unsplash/CC0 Public DomainA combination of immunotherapy and targeted therapies show promise in managing metastatic renal cell carcinoma (RCC), the

Updated on: April 28,2024

Molecular subtypes of advanced kidney cancer matter for treatment response

by Yale Cancer Center/Smilow Cancer HospitalCredit: Unsplash/CC0 Public DomainA combination of immunotherapy and targeted therapies show promise in managing metastatic renal cell carcinoma (RCC), the

Updated on:April 28,2024

Amivantamab-lazertinib ups survival in EGFR-mutated advanced lung cancer

by Elana GotkineFor patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), amivantamab-lazertinib yields improved progression-free survival compared with osimertinib as first-line tre

Updated on: July 08,2024

Amivantamab-lazertinib ups survival in EGFR-mutated advanced lung cancer

by Elana GotkineFor patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), amivantamab-lazertinib yields improved progression-free survival compared with osimertinib as first-line tre

Updated on:July 08,2024

Epidemiological studies on gastroesophageal reflux disease and esophageal cancer

byKarolinska InstitutetCredit: Pixabay/CC0 Public DomainEsophageal cancer is the seventh most common cancer world-wide and a lethal malignancy causing a considerably high number of deaths. There

Updated on: January 10,2024

Epidemiological studies on gastroesophageal reflux disease and esophageal cancer

byKarolinska InstitutetCredit: Pixabay/CC0 Public DomainEsophageal cancer is the seventh most common cancer world-wide and a lethal malignancy causing a considerably high number of deaths. There

Updated on:January 10,2024

The new prostate cancer blood test with 94 per cent accuracy

byUniversity of East AngliaProstate cancer cells. Credit: NIH Image GalleryResearchers at the University of East Anglia have helped develop a new blood test to detect prostate cancer with greate

Updated on: January 12,2024

The new prostate cancer blood test with 94 per cent accuracy

byUniversity of East AngliaProstate cancer cells. Credit: NIH Image GalleryResearchers at the University of East Anglia have helped develop a new blood test to detect prostate cancer with greate

Updated on:January 12,2024

Nirogacestat, a new desmoid tumor treatment, found to improve outcomes for people with sarcoma

byMemorial Sloan Kettering Cancer CenterCredit:New England Journal of Medicine(2023). DOI: 10.1056/NEJMoa2210140When Dana Avellino, now 36, first noticed a lump near her groin in the

Updated on: January 11,2024

Nirogacestat, a new desmoid tumor treatment, found to improve outcomes for people with sarcoma

byMemorial Sloan Kettering Cancer CenterCredit:New England Journal of Medicine(2023). DOI: 10.1056/NEJMoa2210140When Dana Avellino, now 36, first noticed a lump near her groin in the

Updated on:January 11,2024

New treatment approach shows promise in hard-to-treat pediatric cancers

byFlorida International UniversityResearcher Diana Azzam and Logan Jenner, a participant in her clinical study, in the Azzam Lab at Florida International University. Credit: Florida Internationa

Updated on: April 28,2024

New treatment approach shows promise in hard-to-treat pediatric cancers

byFlorida International UniversityResearcher Diana Azzam and Logan Jenner, a participant in her clinical study, in the Azzam Lab at Florida International University. Credit: Florida Internationa

Updated on:April 28,2024

Researchers find a new class of biomarkers to predict treatment outcomes in cancer patients

by Kathryn F. Sykes , Medical XpressCancer is the result of the uncontrolled division and spread of cells into surrounding tissue. Recently researchers have begun to focus on biomarkers as a source of

Updated on: January 30,2024

Researchers find a new class of biomarkers to predict treatment outcomes in cancer patients

by Kathryn F. Sykes , Medical XpressCancer is the result of the uncontrolled division and spread of cells into surrounding tissue. Recently researchers have begun to focus on biomarkers as a source of

Updated on:January 30,2024